AI assistant
Sending…
ORACLE CORP — Director's Dealing 2012
Dec 20, 2012
29742_dirs_2012-12-20_33ae8928-ef99-4060-95f9-52b44353d959.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORACLE CORP (ORCL)
CIK: 0001341439
Period of Report: 2012-12-19
Reporting Person: HENLEY JEFFREY (Director, Chairman of the Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-19 | Common Stock | M | 350000 | $12.60 | Acquired | 350000 | Direct |
| 2012-12-19 | Common Stock | S | 350000 | $33.9249 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-19 | Stock Option | $12.60 | M | 350000 | Disposed | 2013-07-11 | Common Stock (350000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1934516 | Indirect |
Footnotes
F1: Sale of shares pursuant to Rule 10b5-1 Plan adopted on July 5, 2012.
F2: This transaction was executed in multiple trades at prices ranging from $33.84 to $34.05. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Options vest 25% annually on anniversary of grant date.
More from ORACLE CORP
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 11
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 2